Market revenue in a mouse model will rise to $1,327 million by 2030, rising at a compound annual growth rate of 8.6% according to Acumen Research and Consulting.

Acumen Research and Consulting

Acumen Research and Consulting

Recently published report by Acumen Research and Consulting titled “Rat Model Market Size, Share, Analysis Report and Region Forecast, 2022 – 2030”

Los Angeles, June 22, 2022 (GLOBE NEWSWIRE) – World rat model market It had a volume of $636 million in 2021 and is expected to reach $1,327 million by 2030, with a compound annual growth rate of 8.6% from 2022 to 2030.

Mice are an excellent choice for many experiments due to their physiological similarity to humans. Mice are also a more comfortable option for many researchers because they are easier to feed and less bulky than other complex mammals such as primates. According to research professionals around the world, mouse models have become increasingly important for disease research and experimentation in recent years. The similarity of their genetic makeup to human DNA is one of the main reasons for choosing mice as models for genetic experiments. The scientists were able to investigate a number of physiological and pathological pathways in mice that cannot be achieved in the mouse model due to the unique DNA and physiology.

Request a free report form @

https://www.acumenresearchandconsulting.com/request-sample/2957

Report coverage:

Market

rat model market

Market size 2021

636 million dollars

Market Outlook 2030

1,327 million USD

compound annual growth rate During 2022 – 2030

8.6%

Analysis period

2018 – 2030

base year

2021

forecast data

2022 – 2030

covered slices

By type, technology, service, application, end use, and geography

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

An overview of the main companies

Biomedical Research Models (Biomere), Charles River Laboratories International, Inc., Covance Inc., Envigo, genOway, Horizon Discovery Group plc, Janvier Labs, and Taconic Biosciences, Inc.

Report coverage

Market trends, drivers, restraints, competitive analysis, player rating, regulations analysis

Customization range

10 hours from FREE CUSTOMIZATION and expert advice

Impact of COVID-19 on the rat model industry

The Covid-19 pandemic has required exceptional international cooperation from the biomedical sector. Animal research was necessary to help researchers understand the virus, its transmission mechanisms, and the safety and efficacy of all vaccines developed so far to bring the pandemic closer. The development of COVID-19 is a once-in-a-generation public health problem that has boosted the mouse model market share. The increasing prevalence of COVID-19 patients has had a major impact on the healthcare industry. While clinical trials for COVID-19 were emerging, due to the growth of innovative clinical trial methodologies to advance antiviral drugs and vaccine development, the virus recovered quickly.

Check the detailed table of contents of the report @

https://www.acumenresearchandconsulting.com/table-of-content/rat-model-market

Growth factors of the global rat model market

Researchers choose mice over other species for several reasons. For example, according to behavioral research, mice are better suited for investigations into learning and cognition than other species because they are more capable of learning tasks. The ability of mice to learn, remember and interact provides an advantage over other species, giving insight into basic principles of learning and behavior that can subsequently be applied to human behavior and learning. Moreover, it is now able to more efficiently modify the genome of mice to develop precise and accurate genetic knockouts and use the results to understand human genetic diseases.

The physiological similarities between humans and rats and the increasing applications in healthcare are some of the factors that are working to expand the global rat model market share in the coming years. However, threats from alternative methods and strict regulatory guidelines imposed by many animal rights organizations can hamper market growth. Moreover, increasing production of monoclonal antibodies and increasing consumption of personalized medicine are some of the important trends supporting the growth of mouse model market across the globe.

Global Mouse Model Market Segments

Mice market segmentation includes type, technology, service, application, end use, and region. On the basis of type, the market is segmented into innate, hybrid, supernatural, adapted and immunodeficient. Based on our analysis, the Originals segment achieved a significant market share in 2021.

By technology, the market is segmented into nuclear transferase, embryonic stem cells, microinjection, and others. Among technology, the other segment gained a noteworthy market share in 2021.

Cryopreservation, reproduction, resuscitation, genetic testing, quarantine, and others are the divisions of the service sector. With services, the cryopreservation segment is poised to grow at the fastest compound annual growth rate (CAGR) in the coming years.

Based on applications, the market is segmented into oncology, toxicology, neuroscience, immunology, and others. Toxicology dominated the largest market share, while Immunology achieved a significant growth rate in the coming years.

Furthermore, the end-use division is categorized into academic and research facilities, contract research organizations (CROs), and pharmaceutical and biotechnology companies. Based on our analysis, the pharmaceutical and biotechnology companies segment occupied a significant portion of the market in 2021.

Regional market position rat model

Regional market segments include North America, Latin America, Asia Pacific, Europe, Middle East and Africa. Depending on the regions, North America collected the maximum revenue of the rat model market throughout the forecast period 2022-2030. The dominance of the region is mostly attributed to the large searches in the region for the creation of pharmaceutical and biological products, as well as the presence of a large number of pharmaceutical and biotech companies. Conversely, the prospect of lower cost research in countries such as Japan, India, Thailand and Singapore is expected to spur the growth of the rat model industry in Asia Pacific.

Purchase this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/2957

market players

The rat model industry includes many major players. Leading companies in the rat models market included in the report include Biomedical Research Models (Biomere), Charles River Laboratories International, Inc. , and Covance Inc. , Envigo, genOway, Janvier Labs, Horizon Discovery Group plc, Taconic Biosciences, Inc.

In January 2020, Charles River Laboratories International, Inc. announced the completion of its acquisition of HemaCare Corp. In order to enhance its capabilities in the burgeoning high-growth cell therapy industry.

Browse more research topics on healthcare and the pharmaceutical industry:

The Global tissue and cytology market Its size is expected to grow at a compound annual growth rate of approximately 12.8% From 2020 to 2027 it is expected to reach a market value of about 39.8 billion US dollars by 2027

The The global market for Alzheimer’s disease Its size is expected to grow at a compound annual growth rate of approximately 12.8% From 2020 to 2027 it is expected to reach a market value of about 5647.5 million US dollars by 2027.

The Global primary cell culture market The volume is expected to reach the market value of 5.7 billion USD By 2026, at a compound annual growth rate of 10.5% During the projected time period from 2018 to 2026.

Around Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market-related information and advisory services for the information technology, investment, telecommunications, manufacturing and consumer technology markets. ARC helps investment communities, IT professionals, and entrepreneurs make fact-based decisions about technology procurement and develop company growth strategies to stay competitive in the marketplace. With a team size of over 100 analysts and a collective industry experience of over 200 years, Acumen Research and Consulting ensures to deliver a blend of industry knowledge combined with expertise at both global and country levels.

For the latest update, follow us on Twitter And the, LinkedIn

call us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +14079154157

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com